The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...

Merck MRK announced that the FDA has granted the Breakthrough Therapy designation (BTD) to its B7-H3-directed DXd ...

Results from the Phase II OptiTROP-Lung01 trial (NCT05351788) showed that Sichuan Kelun-Biotech’s sac-TMT combined with ...

Officials said these will significantly enhance outreach to rural and underserved communities that face some of the highest ...

The treatment is one for those suffering with lung cancer who never smoked, a group of patients who account for up to 25% of ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan ...

Never-smokers exposed to high levels of fine particulate air pollution have a significantly greater risk of developing lung ...

Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the ...

Dean Comstock was 27 when he received the frightening diagnosis of terminal lung cancer. The singer and runner had never ...

Lung cancer isn’t just about smoking Lung cancer is a common form of cancer, with an estimated 2.4 million new cases worldwide in 2022, according to the World Health Organization.